Navigation Links
VABC Responds to Study on Use of Cholesterol Lowering Drug Statins on Cancer Patients
Date:12/8/2012

New York, NY (PRWEB) December 08, 2012

On December 8, Voices Against Brain Cancer (VABC) releases a statement in reaction to the results of a new study on taking a cholesterol lowering drug that reduces the death risk in cancer patients.

According to an article on NBC News, “the patients who took statins were about 15 percent less likely to die from their cancer than other cancer patients were, the researchers reported after studying the records of nearly 300,000 people.”

The article affirms that the research is not conclusive since it was only based on studies of past medical records, and further research would be needed to prove that statins do reduce the risk of death in cancer patients. However, according to the article, “studies have shown that by blocking cholesterol production and certain protein interactions in cells, statins may influence the ability of cells to proliferate and migrate through the body. So statins could be reducing the ability of cancer cells to metastasize.”

In reaction to these findings, VABC representative Clay Darrohn stated, “We would definitely like to see more in-depth research of these findings. If conclusive, these studies could be very exciting for further brain cancer research.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations.
#####

Read the full story at http://www.prweb.com/releases/2012/12/prweb10211128.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Probiotic Action Responds an Article on ‘Skin Care Coaches’
2. Chronic Cough Responds to Epilepsy Drug, Study Finds
3. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
4. Too Little Sleep Spurs Appetite-Boosting Hormones: Study
5. Funding Meals on Wheels Keeps Seniors Independent: Study
6. Avastin Wont Extend Breast Cancer Survival: Study
7. Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers
8. Kids With Autism Common Users of ERs, Study Says
9. Study compares standard against newer treatment in women whose breast cancer has spread
10. Just Lowering Fat Intake Can Shed Pounds, Study Finds
11. Fasting may benefit patients with epilepsy, Johns Hopkins Childrens Center study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for certain ... Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: